Theriva™ Biologics anuncia varias presentaciones en congresos médicos
VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025
Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced upcoming presentations at the European Society for Medical Oncology (ESMO 2025) Annual Congress and at Infectious Diseases Week (IDWeek) 2025 Annual Meeting.
VCN-01 upcoming mini-oral presentation at ESMO 2025
Expanded data from the VIRAGE trial investigating VCN-01 (zabilugene almadenorepvec) are to be presented at a mini oral session at the ESMO 2025 Congress:
- Presenting author: Dr. Rocío Garcia-Carbonero, Hospital 12 de Octubre, Madrid, Spain
- Title: VIRAGE trial: randomized Phase IIb, open-label, study of Nab-Paclitaxel and Gemcitabine with/without intravenous VCN-01 in Patients with Metastatic Pancreatic Cancer (mPDAC)
- Abstract #: 2216MO
- Date and time: Monday, October 20, 2025, 09:28 a.m. CEST
- Session: Mini oral session 2, GI Tumors Upper digestive
- Location: Bonn Auditorium - Hall 7.1c, Messe Berlin, Berlin, Germany
SYN-004 upcoming poster presentation at IDWeek 2025
Previously disclosed blinded safety and pharmacokinetic (PK) data from the ongoing Phase 1b/2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant (HCT) recipients for the prevention of acute graft-versus-host-disease (aGVHD). These data will be presented at ID Week 2025:
- Presenting Author: Erik R. Dubberke, MD, Professor of Medicine, Clinical Director, Transplant Infectious Diseases, Washington University School of Medicine in St. Louis
- Title: Safety and tolerability of SYN-004 in allogeneic haematopoietic cell transplant (HCT) recipients receiving meropenem (MER) or piperacillin/tazobactam (P/T)
- Abstract #: P-104
- Date and time: Monday, October 20, 2025 from 12:15 to 1:30 p.m US EDT
- Location: Poster Hall B4-5, Georgia World Congress Center, Atlanta, Georgia